Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Talks · SciRah

Researcher profile · Semantic Scholar

J. Talks

Share profile

J. Talks — researcher profile on SciRah

h-index: 25
Works: 106
Citations: 2,515

Most-cited papers

Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial.
S. Sivaprasad, A. Prevost, Joana C. Vasconcelos, A. Riddell +41 more
2017The Lancet316 citations Open access
Semantic Scholar
TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES: A Literature Review and Consensus Recommendations
K. B. Freund, J. Korobelnik, R. Devenyi, C. Framme +11 more
2015Retina266 citations Open access
Semantic Scholar
Defining response to anti-VEGF therapies in neovascular AMD
W. Amoaku, U. Chakravarthy, R. Gale, M. Gavin +12 more
2015Eye253 citations Open access
Semantic Scholar
Defining response to anti-VEGF therapies in neovascular AMD
W. Amoaku, U. Chakravarthy, R. Gale, M. Gavin +12 more
2015Eye180 citations Open access
Semantic Scholar
Anti-vascular endothelial growth factor in neovascular age-related macular degeneration – a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems
R. Finger, V. Daien, B. Eldem, J. Talks +6 more
2020BMC Ophthalmology129 citations Open access
Semantic Scholar
Stakeholder Perspectives of Clinical Artificial Intelligence Implementation: Systematic Review of Qualitative Evidence
H. Hogg, M. Al-Zubaidy, J. Talks, A. Denniston +7 more
2022Journal of Medical Internet Research128 citations Open access
Semantic Scholar
First-Year Visual Acuity Outcomes of Providing Aflibercept According to the VIEW Study Protocol for Age-Related Macular Degeneration.
J. Talks, A. Lotery, F. Ghanchi, S. Sivaprasad +12 more
2016Ophthalmology (Rochester, Minn.)110 citations
Semantic Scholar
Real-world experience with 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN) in the United Kingdom
C. Bailey, U. Chakravarthy, A. Lotery, G. Menon +1 more
2017Eye99 citations Open access
Semantic Scholar
Macular ischaemia: a contraindication for anti-VEGF treatment in retinal vascular disease?
K. Manousaridis, J. Talks
2012British Journal of Ophthalmology97 citations
Semantic Scholar
Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidence
V. Daien, R. Finger, J. Talks, P. Mitchell +4 more
2020British Journal of Ophthalmology69 citations Open access
Semantic Scholar
The use of optical coherence tomography angiography for detecting choroidal neovascularization, compared to standard multimodal imaging
T. Soomro, J. Talks
2018Eye51 citations Open access
Semantic Scholar
DIAbetic Macular Oedema aNd Diode Subthreshold micropulse laser (DIAMONDS): A randomized double-masked non-inferiority clinical trial.
N. Lois, C. Campbell, Norman Waugh, A. Azuara-Blanco +23 more
2022Ophthalmology (Rochester, Minn.)50 citations Open access
Semantic Scholar
Delayed follow-up of medical retina patients due to COVID-19: impact on disease activity and visual acuity
L. Stone, M. Grinton, J. Talks
2021Graefe's Archive for Clinical and Experimental Ophthalmology50 citations Open access
Semantic Scholar
Wide-field imaging and OCT vs clinical evaluation of patients referred from diabetic retinopathy screening
Vina Manjunath, V. Papastavrou, David H. W. Steel, G. Menon +3 more
2015Eye46 citations Open access
Semantic Scholar
Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial.
A. Lotery, S. Sivaprasad, A. O'Connell, Rosie A. Harris +72 more
2020The Lancet41 citations Open access
Semantic Scholar
Second-year visual acuity outcomes of nAMD patients treated with aflibercept: data analysis from the UK Aflibercept Users Group
H. Almuhtaseb, R. Johnston, J. Talks, A. Lotery
2017Eye36 citations Open access
Semantic Scholar
United Kingdom Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group: report 4, real-world data on the impact of deprivation on the presentation of diabetic eye disease at hospital services
A. Denniston, Aaron Y. Lee, Cecilia S. Lee, D. Crabb +28 more
2018British Journal of Ophthalmology34 citations Open access
Semantic Scholar
Extended real-world experience with the ILUVIEN® (fluocinolone acetonide) implant in the United Kingdom: 3-year results from the Medisoft® audit study
C. Bailey, U. Chakravarthy, A. Lotery, G. Menon +1 more
2021Eye30 citations Open access
Semantic Scholar
The use of real-world evidence for evaluating anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration.
J. Talks, V. Daien, R. Finger, B. Eldem +5 more
2019Survey of ophthalmology30 citations Open access
Semantic Scholar
The use of optical coherence tomography angiography and optical coherence tomography to predict visual acuity in diabetic retinopathy
Joanna DaCosta, Devangna Bhatia, J. Talks
2019Eye29 citations Open access
Semantic Scholar
Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy – a systematic approach to identify and characterize data sources
V. Daien, B. Eldem, J. Talks, J. Korobelnik +7 more
2019BMC Ophthalmology28 citations Open access
Semantic Scholar
Aflibercept in wet AMD beyond the first year of treatment: recommendations by an expert roundtable panel
M. Mckibbin, H. Devonport, R. Gale, M. Gavin +7 more
2015Eye28 citations Open access
Semantic Scholar
Ten-Year Real-World Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration
M. R. Cheema, Joanna DaCosta, J. Talks
2021Clinical Ophthalmology26 citations Open access
Semantic Scholar
Diabetic macular oedema and diode subthreshold micropulse laser (DIAMONDS): study protocol for a randomised controlled trial
N. Lois, Evie Gardner, N. Waugh, A. Azuara-Blanco +23 more
2019Trials25 citations Open access
Semantic Scholar
Macula service evaluation and assessing priorities for anti-VEGF treatment in the light of COVID-19
L. Stone, Adele Devenport, I. Stratton, J. Talks
2020Graefe's Archive for Clinical and Experimental Ophthalmology20 citations Open access
Semantic Scholar
Aflibercept treatment for neovascular AMD beyond the first year: consensus recommendations by a UK expert roundtable panel, 2017 update
P. Patel, H. Devonport, S. Sivaprasad, A. Ross +6 more
2017Clinical Ophthalmology20 citations Open access
Semantic Scholar
The changing landscape for the management of patients with neovascular AMD: brolucizumab in clinical practice
I. Pearce, W. Amoaku, C. Bailey, L. Downey +8 more
2022Eye19 citations Open access
Semantic Scholar
Aflibercept-Real life clinical data in the management of Wet age related macular degeneration (Wet AMD)
A. Kotagiri, J. Talks, D. Varma, Rajen Gupta +2 more
201418 citations
Semantic Scholar
Diabetic Macular Edema and Diode Subthreshold Micropulse Laser A Randomized Double-Masked Noninferiority Clinical Trial
N. Lois, C. Campbell, Norman Waugh, A. Azuara-Blanco +23 more
202216 citations
Semantic Scholar
Action on sickle cell retinopathy: the time is now
C. Dinah, Brigit F. Greystoke, Isabella Mueller, J. Talks
2022Eye16 citations Open access
Semantic Scholar
Real-world service costs for neovascular-AMD clinics in the United Kingdom: structured literature review and scenario analysis
S. Sivaprasad, C. Bailey, L. Downey, Rose Gilbert +11 more
2024Current Medical Research and Opinion15 citations Open access
Semantic Scholar
Aflibercept in clinical practice; visual acuity, injection numbers and adherence to treatment, for diabetic macular oedema in 21 UK hospitals over 3 years
S. Talks, I. Stratton, T. Peto, A. Lotery +29 more
2021Eye15 citations Open access
Semantic Scholar
Real-world treatment patterns and visual outcomes of faricimab in patients with diabetic macular oedema in the UK at 12 months: the FARWIDE-DMO study
T. Peto, I. Pearce, J. Talks, G. de Salvo +14 more
2025Eye14 citations Open access
Semantic Scholar
Evaluation of standard of care intravitreal aflibercept treatment of diabetic macular oedema treatment-naive patients in the UK: DRAKO study 12-month outcomes
S. Sivaprasad, F. Ghanchi, S. P. Kelly, Ajay Kotagiri +6 more
2021Eye13 citations Open access
Semantic Scholar
Treatment patterns and long-term outcomes in anti-VEGF-treated macular oedema secondary to retinal vein occlusion: a retrospective observational study
C. Dinah, M. Dodds, A. Lotery, S. Salvatore +20 more
2025Eye12 citations Open access
Semantic Scholar
Appropriateness of quality standards for meaningful intercentre comparisons of aflibercept service provision for neovascular age-related macular degeneration
J. Talks, P. James, S. Sivaprasad, R. Johnston +1 more
2017Eye12 citations Open access
Semantic Scholar
Safety and efficacy of an artificial intelligence-enabled decision tool for treatment decisions in neovascular age-related macular degeneration and an exploration of clinical pathway integration and implementation: protocol for a multi-methods validation study
H. Hogg, K. Brittain, D. Teare, J. Talks +3 more
2023BMJ Open10 citations Open access
Semantic Scholar
Evaluation of care with intravitreal aflibercept treatment for UK patients with diabetic macular oedema: DRAKO study 24-month real-world outcomes
S. Sivaprasad, F. Ghanchi, S. P. Kelly, Ajay Kotagiri +6 more
2023Eye10 citations Open access
Semantic Scholar
Associations of presenting visual acuity with morphological changes on OCT in neovascular age-related macular degeneration: PRECISE Study Report 2
S. Chandra, S. Gurudas, B. Burton, G. Menon +16 more
2023Eye8 citations Open access
Semantic Scholar
Multiple Evanescent White Dot Syndrome and Choroidal Neovascularization following SARS-COV-2 Infection in a Patient on Dabrafenib and Trametinib
Beatrice Gallo, J. Talks, R. Pandit, A. Browning
2022Ocular immunology and inflammation8 citations
Semantic Scholar
Baseline characteristics of eyes with early residual fluid post loading phase of aflibercept therapy in neovascular AMD: PRECISE study report 3
S. Chandra, S. Gurudas, I. Pearce, M. Mckibbin +14 more
2023Eye7 citations Open access
Semantic Scholar
A novel tool to assess the quality of RWE to guide the management of retinal disease
R. Finger, V. Daien, J. Talks, P. Mitchell +5 more
2020Acta ophthalmologica7 citations Open access
Semantic Scholar
A Multi-Modal AI-Driven Cohort Selection Tool to Predict Suboptimal Non-Responders to Aflibercept Loading-Phase for Neovascular Age-Related Macular Degeneration: PRECISE Study Report 1
Michal Chorev, Jonas F. Haderlein, S. Chandra, G. Menon +18 more
2023Journal of Clinical Medicine6 citations Open access
Semantic Scholar
Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT.
N. Lois, C. Campbell, Norman Waugh, A. Azuara-Blanco +23 more
2022Health Technology Assessment6 citations Open access
Semantic Scholar
Utilisation of optical coherence tomography and optical coherence tomography angiography to assess retinal neovascularisation in diabetic retinopathy
Joanna DaCosta, Devangna Bhatia, Oonagh Crothers, J. Talks
2021Eye6 citations Open access
Semantic Scholar
Information Used to Decide on Retreatment of Exudative Age-Related Macular Degeneration with anti-VEGF in Clinical Practice
K. Manousaridis, Vina Manjunath, J. Talks
2013European Journal of Ophthalmology6 citations
Semantic Scholar
Intervention design for artificial intelligence-enabled macular service implementation: a primary qualitative study
H. Hogg, Katie Brittain, J. Talks, P. Keane +7 more
2024Implementation Science Communications5 citations Open access
Semantic Scholar
Impact of treat and extend criteria on proportions that can be extended after loading phase of 2 mg aflibercept therapy for neovascular age related macular degeneration: PRECISE Report 5
Sridevi Thottarath, S. Gurudas, Swati Chandak, P. Patel +12 more
2024Eye5 citations Open access
Semantic Scholar
Intravitreal aflibercept for neovascular age-related macular degeneration in patients aged 90 years or older: 2-year visual acuity outcomes
I. Chatziralli, Shane O Regan, Ryian Mohamed, J. Talks +1 more
2018Eye5 citations Open access
Semantic Scholar
Deep-learning algorithm for the diagnosis and prediction of hydroxychloroquine retinopathy: An International, multi-institutional study.
Peter Woodward-Court, Jeffry Hogg, Terry Lee, Priyal Taribagil +14 more
2025Ophthalmology Retina4 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Sivaprasad×19
Invite
S. Sivaprasad — researcher profile on SciRah
F. Ghanchi×18
Invite
F. Ghanchi — researcher profile on SciRah
G. Menon×14
Invite
G. Menon — researcher profile on SciRah
C. Bailey×11
Invite
C. Bailey — researcher profile on SciRah

×10

Invite

A. Lotery — researcher profile on SciRah

U. Chakravarthy×9

Invite

U. Chakravarthy — researcher profile on SciRah

Ajay Kotagiri×7

Invite

Ajay Kotagiri — researcher profile on SciRah

Invite

T. Peto — researcher profile on SciRah

J. Korobelnik×6

Invite

J. Korobelnik — researcher profile on SciRah

Invite

P. Mitchell — researcher profile on SciRah

Invite

R. Gale — researcher profile on SciRah

Invite

S. Mahmood — researcher profile on SciRah